EarningsQ2 2023 Earnings Report

Novartis (NVSN) Q2 2023 Earnings Report

0 Followers

MX:NVSN Q2 2023 EPS Results

Actual EPS$31.34

Consensus EPS$29.62

Beat/MissBeat by +$1.72

One Year Ago EPS$26.73

Actual Revenue$246.15B

Expected Revenue$243.53B

Beat/MissBeat by +$2.62B

YoY Revenue Growth+6.56%

QuarterQ2 2023

Date07/18/2023

TimeBefore Open

Conference CallTuesday, July 18, 2023

MX:NVSN Upcoming Earnings

Novartis's next earnings date is estimated for October 27, 2026, based on past reporting schedules.

MX:NVSN Q2 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 27, 2026	2026 (Q3)	40.99 / -	40.665	―
Jul 21, 2026	2026 (Q2)	39.26 / 43.56	43.738	-0.41% (-0.18)
Apr 28, 2026	2026 (Q1)	37.92 / 35.97	41.207	-12.72% (-5.24)
Feb 04, 2026	2025 (Q4)	35.84 / 36.69	35.785	2.53% (+0.90)
Oct 28, 2025	2025 (Q3)	41.08 / 40.67	37.231	9.22% (+3.43)
Jul 17, 2025	2025 (Q2)	42.49 / 43.74	35.605	22.84% (+8.13)
Apr 29, 2025	2025 (Q1)	38.21 / 41.21	32.532	26.67% (+8.68)
Jan 31, 2025	2024 (Q4)	32.62 / 35.79	27.652	29.41% (+8.13)
Oct 29, 2024	2024 (Q3)	35.03 / 37.23	31.448	18.39% (+5.78)
Jul 18, 2024	2024 (Q2)	33.44 / 35.60	31.339	13.61% (+4.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed